ELECTROMED INC (ELMD) Stock Fundamental Analysis
NYSEARCA:ELMD - NYSE Arca - US2854091087 - Common Stock - Currency: USD
Taking everything into account, ELMD scores 7 out of 10 in our fundamental rating. ELMD was compared to 187 industry peers in the Health Care Equipment & Supplies industry. ELMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ELMD is growing strongly while it is still valued neutral. This is a good combination! This makes ELMD very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year ELMD was profitable.
In the past year ELMD had a positive cash flow from operations.
ELMD had positive earnings in each of the past 5 years.
Of the past 5 years ELMD 4 years had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 13.65%, ELMD belongs to the best of the industry, outperforming 95.72% of the companies in the same industry.
ELMD has a better Return On Equity (16.30%) than 91.44% of its industry peers.
ELMD has a better Return On Invested Capital (15.35%) than 96.26% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ELMD is in line with the industry average of 7.89%.
The last Return On Invested Capital (15.35%) for ELMD is above the 3 year average (8.56%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.65% | ||
| ROE | 16.3% | ||
| ROIC | 15.35% |
ROA(3y)7.45%
ROA(5y)8.24%
ROE(3y)8.9%
ROE(5y)9.55%
ROIC(3y)8.56%
ROIC(5y)8.69%
1.3 Margins
ELMD has a better Profit Margin (11.66%) than 88.77% of its industry peers.
ELMD's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 14.58%, ELMD belongs to the best of the industry, outperforming 84.49% of the companies in the same industry.
In the last couple of years the Operating Margin of ELMD has grown nicely.
ELMD's Gross Margin of 77.55% is amongst the best of the industry. ELMD outperforms 91.44% of its industry peers.
In the last couple of years the Gross Margin of ELMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.58% | ||
| PM (TTM) | 11.66% | ||
| GM | 77.55% |
OM growth 3Y11.05%
OM growth 5Y5.84%
PM growth 3Y12.53%
PM growth 5Y8.27%
GM growth 3Y-0.05%
GM growth 5Y0.02%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ELMD is creating some value.
The number of shares outstanding for ELMD has been increased compared to 1 year ago.
The number of shares outstanding for ELMD has been increased compared to 5 years ago.
ELMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
ELMD has an Altman-Z score of 16.16. This indicates that ELMD is financially healthy and has little risk of bankruptcy at the moment.
ELMD has a better Altman-Z score (16.16) than 92.51% of its industry peers.
There is no outstanding debt for ELMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 16.16 |
ROIC/WACC1.72
WACC8.93%
2.3 Liquidity
ELMD has a Current Ratio of 5.19. This indicates that ELMD is financially healthy and has no problem in meeting its short term obligations.
ELMD's Current ratio of 5.19 is fine compared to the rest of the industry. ELMD outperforms 76.47% of its industry peers.
A Quick Ratio of 4.84 indicates that ELMD has no problem at all paying its short term obligations.
The Quick ratio of ELMD (4.84) is better than 78.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.19 | ||
| Quick Ratio | 4.84 |
3. Growth
3.1 Past
ELMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.00%, which is quite impressive.
Measured over the past years, ELMD shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.42% on average per year.
ELMD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.85%.
Measured over the past years, ELMD shows a quite strong growth in Revenue. The Revenue has been growing by 11.82% on average per year.
EPS 1Y (TTM)58%
EPS 3Y30.66%
EPS 5Y20.42%
EPS Q2Q%23.53%
Revenue 1Y (TTM)14.85%
Revenue growth 3Y15.24%
Revenue growth 5Y11.82%
Sales Q2Q%13.07%
3.2 Future
Based on estimates for the next years, ELMD will show a very strong growth in Earnings Per Share. The EPS will grow by 26.83% on average per year.
Based on estimates for the next years, ELMD will show a quite strong growth in Revenue. The Revenue will grow by 12.42% on average per year.
EPS Next Y42.45%
EPS Next 2Y30.94%
EPS Next 3Y26.83%
EPS Next 5YN/A
Revenue Next Year15.21%
Revenue Next 2Y13.44%
Revenue Next 3Y12.42%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
ELMD is valuated quite expensively with a Price/Earnings ratio of 27.84.
ELMD's Price/Earnings ratio is a bit cheaper when compared to the industry. ELMD is cheaper than 77.01% of the companies in the same industry.
ELMD is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.15, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 22.11, ELMD is valued on the expensive side.
ELMD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ELMD is cheaper than 77.01% of the companies in the same industry.
ELMD is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.60, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.84 | ||
| Fwd PE | 22.11 |
4.2 Price Multiples
77.01% of the companies in the same industry are more expensive than ELMD, based on the Enterprise Value to EBITDA ratio.
ELMD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ELMD is cheaper than 90.37% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.6 | ||
| EV/EBITDA | 17.03 |
4.3 Compensation for Growth
ELMD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of ELMD may justify a higher PE ratio.
ELMD's earnings are expected to grow with 26.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.66
PEG (5Y)1.36
EPS Next 2Y30.94%
EPS Next 3Y26.83%
5. Dividend
5.1 Amount
ELMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
21.99
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners50.06%
Inst Owner Change15.62%
Ins Owners7.54%
Ins Owner Change2.54%
Market Cap184.50M
Analysts82.5
Price Target37.74 (71.62%)
Short Float %2.48%
Short Ratio2.63
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.38%
Min EPS beat(2)2.94%
Max EPS beat(2)19.83%
EPS beat(4)4
Avg EPS beat(4)121.43%
Min EPS beat(4)2.94%
Max EPS beat(4)422.88%
EPS beat(8)6
Avg EPS beat(8)63.79%
EPS beat(12)8
Avg EPS beat(12)51.09%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.89%
Min Revenue beat(2)-2.37%
Max Revenue beat(2)4.16%
Revenue beat(4)2
Avg Revenue beat(4)1.31%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)6.52%
Revenue beat(8)4
Avg Revenue beat(8)0.61%
Revenue beat(12)6
Avg Revenue beat(12)0.85%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.44%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.84 | ||
| Fwd PE | 22.11 | ||
| P/S | 3 | ||
| P/FCF | 15.6 | ||
| P/OCF | 15.35 | ||
| P/B | 4.2 | ||
| P/tB | 4.26 | ||
| EV/EBITDA | 17.03 |
EPS(TTM)0.79
EY3.59%
EPS(NY)0.99
Fwd EY4.52%
FCF(TTM)1.41
FCFY6.41%
OCF(TTM)1.43
OCFY6.52%
SpS7.32
BVpS5.24
TBVpS5.17
PEG (NY)0.66
PEG (5Y)1.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.65% | ||
| ROE | 16.3% | ||
| ROCE | 20.38% | ||
| ROIC | 15.35% | ||
| ROICexc | 23.51% | ||
| ROICexgc | 24% | ||
| OM | 14.58% | ||
| PM (TTM) | 11.66% | ||
| GM | 77.55% | ||
| FCFM | 19.25% |
ROA(3y)7.45%
ROA(5y)8.24%
ROE(3y)8.9%
ROE(5y)9.55%
ROIC(3y)8.56%
ROIC(5y)8.69%
ROICexc(3y)11.98%
ROICexc(5y)12.69%
ROICexgc(3y)12.25%
ROICexgc(5y)13.03%
ROCE(3y)11.36%
ROCE(5y)11.53%
ROICexcg growth 3Y14.49%
ROICexcg growth 5Y7.7%
ROICexc growth 3Y14.84%
ROICexc growth 5Y7.9%
OM growth 3Y11.05%
OM growth 5Y5.84%
PM growth 3Y12.53%
PM growth 5Y8.27%
GM growth 3Y-0.05%
GM growth 5Y0.02%
F-Score8
Asset Turnover1.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 19.8% | ||
| Cap/Sales | 0.32% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 120.96% | ||
| Profit Quality | 165.17% | ||
| Current Ratio | 5.19 | ||
| Quick Ratio | 4.84 | ||
| Altman-Z | 16.16 |
F-Score8
WACC8.93%
ROIC/WACC1.72
Cap/Depr(3y)189.91%
Cap/Depr(5y)155.01%
Cap/Sales(3y)2.65%
Cap/Sales(5y)2.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58%
EPS 3Y30.66%
EPS 5Y20.42%
EPS Q2Q%23.53%
EPS Next Y42.45%
EPS Next 2Y30.94%
EPS Next 3Y26.83%
EPS Next 5YN/A
Revenue 1Y (TTM)14.85%
Revenue growth 3Y15.24%
Revenue growth 5Y11.82%
Sales Q2Q%13.07%
Revenue Next Year15.21%
Revenue Next 2Y13.44%
Revenue Next 3Y12.42%
Revenue Next 5YN/A
EBIT growth 1Y56.01%
EBIT growth 3Y27.97%
EBIT growth 5Y18.35%
EBIT Next Year137.93%
EBIT Next 3Y45.86%
EBIT Next 5YN/A
FCF growth 1Y648.35%
FCF growth 3Y48.86%
FCF growth 5Y48.48%
OCF growth 1Y2942.32%
OCF growth 3Y43.37%
OCF growth 5Y28.48%